These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Facilitation of thrombolysis in acute myocardial infarction. Gambhir DS Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636 [No Abstract] [Full Text] [Related]
7. [Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction]. Tereshchenko SN; Aleksandriia LG; Moiseev VS Kardiologiia; 2002; 42(10):19-21. PubMed ID: 12494051 [No Abstract] [Full Text] [Related]
8. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis? Shah PK Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975 [No Abstract] [Full Text] [Related]
9. Antithrombotics and antiplatelets in acute myocardial infarction. Wander GS; Gupta NK Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866 [No Abstract] [Full Text] [Related]
10. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424 [TBL] [Abstract][Full Text] [Related]
11. Aspirin augmentation of the efficacy of thrombolysis. O'Donnell CJ; Jonas MA; Hennekens CH Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015 [No Abstract] [Full Text] [Related]
14. Antithrombotic and thrombolytic therapy in acute cardiac care. Sundrani R; Klein LW Crit Care Clin; 2001 Apr; 17(2):379-90, vii. PubMed ID: 11450322 [TBL] [Abstract][Full Text] [Related]
15. [Acute myocardial infarction: what is new?]. Boulé S; Gongora A; Randriamora M; Adala D; Courteaux C; Taghipour K; Rifaï A; Bearez E; Hannebicque G Ann Cardiol Angeiol (Paris); 2005 Nov; 54(6):344-52. PubMed ID: 17183831 [TBL] [Abstract][Full Text] [Related]
16. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. Collins R; Peto R; Baigent C; Sleight P N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095 [No Abstract] [Full Text] [Related]
17. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach. Gulba DC Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809 [No Abstract] [Full Text] [Related]
18. Adjuvants to thrombolysis after acute myocardial infarction. Does adding antiplatelet agents, antithrombotics, or angioplasty make a difference? Figueredo VM; Amidon TM; Wolfe CL Postgrad Med; 1994 Dec; 96(8):45-51, 54. PubMed ID: 7991477 [TBL] [Abstract][Full Text] [Related]
19. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review". Howlett M MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208 [No Abstract] [Full Text] [Related]
20. [First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors]. Ferreira R Rev Port Cardiol; 1992 Mar; 11(3):261-4. PubMed ID: 1610612 [No Abstract] [Full Text] [Related] [Next] [New Search]